This guide offers a comprehensive overview of endometrial cancer, including insights into its diagnosis, treatment options, and ongoing monitoring.

Designed to support patients and their families, it covers the essential aspects of managing this condition, from understanding the disease and available treatments to navigating the emotional challenges of the cancer journey.

Understanding the Structure and Function of the Uterus in Female Reproduction

The womb, or uterus, is a vital internal organ in the female reproductive system. Positioned in the center of the small pelvis, between the urinary bladder and the rectum, it takes on the shape of a pear that leans forward at its thin part.

The uterus consists of two main parts: the cervix and the corpus uteri. The cervix, which is the lower and narrower section, connects to the vagina. The upper portion of the uterus is known as the body, where conception, development, and growth of the fetus occur until birth.

At the top of the uterine body lies the fundus, which is the enlarged area where the fallopian tubes enter the uterine cavity.

The uterine body has a thick, muscular wall composed of three layers. Externally, it is enveloped by a thin connective tissue layer, also known as the perimeter. Beneath this lies a remarkably strong and flexible middle layer of uterine muscle called the myometrium.

In women with a normally positioned uterus, this muscular layer measures around 2 centimeters in thickness. The innermost layer of the uterine wall is the endometrium, which is the lining of the uterus.

It consists of two parts: the base layer and the functional layer.

In mature women, the lining of the uterus undergoes cyclical changes, driven by sex hormones, on a monthly basis. Each cycle prepares the uterine lining for pregnancy.

If pregnancy does not occur, the functional layer is shed, resulting in menstruation. Following the menstrual period, the mucous membrane regenerates from the basal layer, getting ready for a potential pregnancy.

In the case of pregnancy, hormones related to pregnancy prevent further menstrual bleeding, and the fetus grows within the uterus.

In this informative booklet, our focus will be on endometrial cancer (uterine body cancer). This type of cancer develops from the cells lining the body of the uterus.

Understanding Cancer: Unraveling the Nature of Abnormal Cell Growth

Cancer is a condition that arises when the cells in our body undergo certain changes, causing them to defy the normal rules of growth and reproduction.

While cells in different organs possess distinct structures and functions, their reproductive processes are fundamentally the same. In a healthy state, cell proliferation occurs in an orderly and controlled manner.

However, when exposed to various harmful factors, cells within a particular organ may undergo alterations that make them “disobey” the body’s regulatory mechanisms.

Consequently, these cells start multiplying excessively and without restraint, forming a mass of cells known as a tumor.

Tumors can be classified as either benign or malignant. Benign tumors grow in size, but they do not invade adjacent tissues or spread to other parts of the body.

While a benign tumor may cause health issues by exerting pressure on nearby organs, it generally remains confined to its original location.

On the other hand, malignant tumors and cancers possess the ability to invade and infiltrate surrounding tissues and organs, disrupting their normal structure and function.

Another disturbing characteristic of cancer cells is their capacity to break away from the primary tumor site.

Once they detach, these rogue cells can travel through the bloodstream or lymphatic system to distant organs in different parts of the body. There, they can “take root,” multiply, and form secondary cancer sites known as metastases. This process is referred to as cancer metastasis.

In summary, cancer represents an aberrant state of cell growth where cells multiply uncontrollably, invade neighboring tissues, and potentially spread to distant organs through metastasis.

Understanding the nature of cancer is crucial in order to develop effective strategies for prevention, early detection, and treatment.

The Path of Cancer: How Tumors Develop and Spread

Metastasis, the spread of cancer, typically occurs through the lymphatic route. Cancer cells from the primary tumor site travel via small lymphatic vessels and tend to accumulate in the nearest lymph nodes. Within these lymph nodes, the cancer cells multiply, leading to enlargement and the formation of nodules called lymph node conglomerates or peripheral lymphadenopathy.

Once cancer cells break free from the metastatic lymph nodes, they continue their journey through the lymphatic vessels, reaching distant organs far from the original site. In these new locations, they establish secondary tumors through the process of metastasis.

It’s also important to note that cancer cells can spread to distant sites in the body through the bloodstream, carried by blood vessels.

To determine whether a tumor is benign or malignant, a pathologist examines the cells under a microscope. Obtaining tumor cells for analysis can be done in different ways, depending on the tumor’s location in the body.

In a biopsy, a small piece of tumor tissue is surgically removed for examination. Sometimes, suspicious areas are sampled by scraping them with a specialized instrument. After proper preparation, the pathologist carefully observes the material under a microscope.

In everyday life, we often use the term “cancer” to refer to all malignant tumors. However, it’s important to understand that carcinomas specifically refer to malignant tumors that originate from epithelial cells.

Malignant tumors that arise from non-epithelial cells are given different names, such as sarcoma, lymphoma, melanoma, and so on.

Epithelial tissue constitutes the outermost layer of mucous membranes throughout the body. These mucous membranes line the respiratory, digestive, urinary, and genital tracts, including the uterus. In the case of uterine body cancer, approximately 95% of malignant tumors are adenocarcinomas.

They develop from the glandular epithelium of the uterine lining and are referred to as endometrial cancer. A small percentage of uterine malignancies, around 2-4%, are sarcomas. Sarcomas arise from the muscular tissue of the uterus and have distinct characteristics.

Endometrial Cancer Risk Factors

Prevention

To comprehend the risk factors associated with uterine body cancer, it’s essential to understand that certain factors can increase an individual’s likelihood of developing this disease.

While some risk factors can be influenced by personal choices, such as smoking, others are beyond our control, including age, gender, and family history.

While not everyone exposed to these risk factors will develop cancer, it’s valuable to be aware of them and take appropriate precautions.

Let’s explore the key risk factors associated with this condition:

• Age: Uterine body cancer predominantly affects women aged 50 and above, typically during their menopausal years. The average age of diagnosis is around 60, and it is relatively rare for women under the age of 40 to develop this type of cancer.

• Estrogens: Prolonged exposure to the female hormone estrogen in a woman’s body increases the risk of uterine body cancer. This can occur when a girl starts menstruating at an early age or when a woman experiences late-onset menopause. Girls typically begin menstruation around the age of 11-13, while menopause begins around the age of 51. If a woman undergoes hormone replacement therapy (HRT) after menopause, estrogen exposure may be extended. HRT involves the use of female hormones to alleviate menopausal symptoms.

The risk of cancer is higher when using estrogen-only HRT compared to estrogen combined with progesterone. Prolonged use of HRT beyond five years further elevates the risk. Additionally, women who have not given birth may experience longer-lasting effects of estrogen.

• Obesity: Weight status plays a significant role in uterine cancer risk, with higher body weight correlating to an increased likelihood of developing the disease.

This association is attributed to the additional production of estrogen in adipose (fat) tissue, which heightens the risk of uterine body cancer. It is noteworthy that at least four out of ten women diagnosed with uterine cancer are significantly overweight or obese.

By understanding these risk factors, individuals can make informed decisions and take appropriate measures to minimize their chances of developing uterine body cancer. Maintaining a healthy weight, being mindful of hormonal therapies, and seeking regular medical check-ups can contribute to early detection and better overall well-being.

Key Risk Factors for Uterine Body Cancer: Genetics, Medications and Lifestyle

Uterine body cancer risk factors can encompass various aspects of an individual’s health and medical history. Let’s delve into some additional factors that contribute to the risk of developing this form of cancer:

• Inherited genes: Women who inherit a mutated gene associated with hereditary non-polyposis colorectal cancer (HPNCC) face an increased risk not only of colorectal cancer, but also of uterine and ovarian cancer.

• Tamoxifen usage: Tamoxifen is commonly prescribed as a treatment for breast cancer. However, long-term use of this medication slightly elevates the risk of endometrial cancer.

Nevertheless, it’s crucial to note that the benefits of tamoxifen in breast cancer treatment generally outweigh the relatively low risk of uterine cancer.

• Other illnesses: Women with a history of diabetes, breast cancer, colorectal cancer, or ovarian cancer have a higher risk of developing uterine cancer.

• Nutrition: Diets rich in fatty foods of animal origin have been associated with an increased risk of uterine cancer.

• Radiotherapy: Women who have undergone radiotherapy for other pelvic organs such as the rectum, bladder, or pelvic lymph nodes have a higher risk of uterine body cancer.

Contrary to these risk factors, it’s important to note that women who use contraceptives have a lower risk of uterine cancer.

Signs and Symptoms of Uterine Body Cancer

Now, let’s explore the symptoms that may indicate the presence of uterine cancer:

• Abnormal genital bleeding: The most common symptom of uterine body cancer is abnormal bleeding or bloody discharge from the reproductive tract, particularly in women going through menopause.

• Intermenstrual bleeding: For women who are still menstruating, it may be a potential sign of uterine body cancer.

• Experiencing more frequent or heavier menstruations: monthly bleeding that deviates from an individual’s normal pattern may also be indicative of uterine body cancer.

If a woman experiences any of these symptoms, it is important to consult an obstetrician-gynecologist for guidance. It’s crucial to remember that abnormal genital bleeding does not always indicate uterine cancer.

These symptoms can also be associated with other conditions affecting the reproductive organs. Nonetheless, it is essential to identify the underlying cause of the bleeding to receive the necessary evaluation and treatment.

By being aware of these risk factors and recognizing potential symptoms, women can take proactive steps towards early detection and medical intervention for uterine body cancer. Regular check-ups and open communication with healthcare professionals are vital for maintaining optimal reproductive health.

Diagnosing Uterine Body Cancer: Understanding Examination and Imaging Techniques

In addition to the previously mentioned symptoms, there are other potential indicators of uterine body cancer that should be considered:

1. Pain in the loins or lower abdomen: Some women with uterine body cancer may experience pain in the lower back or abdomen, even without uterine bleeding.

2. Painful sexual intercourse: Cancer of the uterine body can also lead to discomfort or pain during sexual intercourse.

When a woman presents with these symptoms, the initial step is to consult an obstetrician-gynecologist. During the examination, the woman is typically seated in a special gynecological examination chair.

The doctor uses vaginal dissectors to gently widen the vagina, allowing for a better view of the vagina and cervix. The lining of the vagina and cervix is carefully examined for any signs of abnormalities, such as the presence of blood.

Through pelvic palpation, the doctor assesses the uterus, ovaries, and fallopian tubes. With one hand placed on the abdomen and two fingers of the other hand inserted into the vagina, gentle pressure is applied from the bottom up to bring the uterus closer to the abdominal wall.

This technique enables the doctor to gather information about the location, size, consistency, shape, and any additional formations present in these organs.

If the gynecological examination reveals an enlarged uterus beyond what is expected during menopause, and the woman reports the aforementioned symptoms, further comprehensive examinations of the uterus are recommended to establish an accurate diagnosis.

One such diagnostic method is uterine echoscopy, which employs high-frequency sound waves and computer technology to generate images of the organs. These images are displayed on a monitor for analysis.

Pelvic ultrasound, specifically focusing on the pelvic organs, including the uterus, is conducted with a full bladder as it enhances visualization. To ensure a clear view, the woman is advised to drink a few glasses of water approximately 30 minutes before the echoscopy.

During the procedure, the woman lies on her back, and the abdomen is coated with a special gel. A sound wave sensor, similar to a microphone, is moved over the abdominal surface.

The resulting images provide information on the size of the uterus, the thickness of its lining, the presence of any additional formations, and the condition of the bladder, ovaries, and fallopian tubes.

These diagnostic examinations and imaging techniques are crucial for a comprehensive evaluation of the uterus and surrounding structures, enabling healthcare professionals to make accurate diagnoses and determine appropriate treatment strategies.

Endometrial Cancer Diagnosis: Biopsy and Diagnostic Procedures

In modern practice, uterine ultrasound often involves a specialized transducer inserted into the vagina, known as vaginal echocardiography.

Unlike traditional ultrasound, this technique does not require a full bladder. Vaginal echocardiography provides a close examination of the uterus and its lining, known as the endometrium.

However, if symptoms, gynecological findings, and echoscopic results suggest uterine cancer, further tests are necessary to confirm the diagnosis.

In such cases, a biopsy of the uterine lining is required, and the obtained tissue sample is examined microscopically. Several methods can be used to perform a uterine lining biopsy, with the specific approach chosen by your doctor.

One method is hysteroscopy and biopsy. Hysteroscopy allows for the examination of the uterine lining from the inside using a specialized device called a hysteroscope. This instrument consists of a light source at one end and an optical system at the other.

During the procedure, the hysteroscope is inserted through the vagina and cervical canal into the uterine cavity. The doctor examines the uterine mucosa from within using the optical system and obtains a sample of the suspicious area for microscopic analysis.

Hysteroscopy and biopsy can be performed under general or local anesthesia. Following the procedure, the woman may experience blood or bloody secretions from the genitals for several days, along with some lower abdominal discomfort.

Another diagnostic procedure is cervical canal dilation and uterine curettage. This minor operation involves dilating the cervical canal using specialized instruments called dilators. This allows for easy insertion of a specific instrument into the uterine cavity to perform uterine curettage, which involves scraping the uterine lining.

Cervical canal dilation and uterine curettage are typically conducted under general anesthesia. After the procedure, the woman may experience bloody or purulent secretions from the genital tract for a few days, along with lower abdominal pain.

The diagnostic procedures, including hysteroscopy and biopsy, as well as cervical canal dilation and uterine curettage, are crucial in establishing a definitive diagnosis of uterine cancer.

While they may entail some discomfort and temporary side effects, they provide essential information for healthcare professionals to determine the most appropriate treatment plan for each individual.

Determining Cancer Stage and Assessing General Health: Additional Tests

To determine the appropriate treatment for uterine body cancer, it is crucial to assess the extent of the disease.

This involves determining whether the cancer is confined to the uterine lining or if it has infiltrated deeper layers of the uterine wall, spread to nearby organs, metastasized to lymph nodes, or affected other distant organs.

To gather this information, additional tests are conducted, alongside assessing the patient’s overall health before initiating treatment.

• Blood tests. They are performed to evaluate general health.These tests include general and biochemical blood tests, which help identify any abnormalities in blood cell counts (such as leukocytes, erythrocytes, and platelets) and assess the functioning of internal organs like the kidneys and liver.

• Chest X-ray. It‘s is typically conducted to examine the condition of the lungs, heart, and other organs within the chest. This test aims to detect any signs of cancer spreading to the lungs.

• Computed tomography (CT). This is a sophisticated X-ray method performed using advanced machines known as computed X-ray tomographs. This imaging technique produces a series of cross-sectional X-ray images of the specific body part under examination. These cross-sectional images provide a comprehensive view of the organs as if the body part had been “sliced” for examination.

Each X-ray image displays all the organs within the “section” and any associated changes. By evaluating these images, doctors can determine whether the cancer has extended beyond the boundaries of the organ or if there is lymph node metastasis.

It’s important to note that not all cases of uterine body cancer require a CT scan. The decision to perform a CT scan is based on the results of previous tests and the doctor’s clinical judgment.

In the case of uterine cancer, pelvic CT scans are performed, and if necessary, CT scans of other areas of the body may also be conducted. During a pelvic CT scan, the woman is given a special contrast agent to drink or inject intravenously a few hours prior to the scan.

This contrast agent enhances the CT images, making them more informative and easier to evaluate. The CT scan is a non-painful procedure performed with the patient lying down. It requires the patient to remain still for about 30-40 minutes. After the test, the patient can return home.

These additional tests, including blood tests, chest X-rays, and CT scans, aid in determining the stage of uterine cancer and evaluating the overall health of the patient.

The information gathered from these tests helps healthcare professionals develop an individualized treatment plan tailored to the specific needs of each patient.

Magnetic Resonance Imaging (MRI): A Detailed Imaging Technique

Another imaging technique used for similar purposes as a CT scan is magnetic resonance imaging (MRI). However, MRI differs in that it utilizes a strong magnetic field instead of X-rays to generate detailed images of the body.

During the examination, the patient lies on a specialized table within a metal cylinder that is open at both ends. The MRI test is entirely painless and typically takes around 30 minutes to complete. However, individuals who experience claustrophobia or fear confined spaces may find the procedure uncomfortable.

It’s important to note that not all cases of uterine body cancer require an MRI, and its necessity is determined by the healthcare professional based on the specific situation.

Given the powerful magnet used in the MRI scanner, it is crucial to remove any metal objects, such as watches or jewelry, before the scan. Additionally, individuals with pacemakers implanted under their skin or metal staples used for tissue closure during surgery cannot undergo an MRI.

Staging Endometrial Cancer: Understanding the Extent of Disease Spread

In oncology, the term “cancer stages” is employed to describe the extent to which cancer has spread.

Generally, there are four stages of cancer:

• Stage 1 or 2 corresponds to small or non-spreading tumors outside the organ;
• Stage 3 involves the spread of cancer to adjacent structures; and
• Stage 4 denotes the spread of cancer to distant organs far from the primary tumor site.

To describe the spread of cancer, oncology employs the TNM symbol system:

• T represents the size of the tumor.
• N indicates the involvement of regional (proximal) lymph nodes.
• M signifies the presence of cancer metastasis in organs distant from the primary tumor.

The stage of uterine body cancer is determined by assessing the TNM values obtained during the patient’s examination, which involves evaluating the size of the tumor and determining if there is metastasis to regional lymph nodes or other organs.

This TNM principle is also applied to stage uterine body cancers, helping healthcare professionals classify and understand the extent of the disease for optimal treatment planning.

Detailed Overview of Endometrial Cancer Stages

The staging of uterine body cancer involves categorizing the extent to which the cancer has spread. Here is an overview of the different stages:

Stage 1:

• Stage 1A: The cancer is limited to the lining of the uterus (endometrium).
• Stage 1B: The cancer has penetrated into the muscular layer of the uterine body wall, but not more than half of its thickness.
• Stage 1C: The cancer has penetrated into the muscular layer of the uterine body wall, more than half of its thickness.

Stage 2:

• Stage 2A: The cancer has spread from the body of the uterus to the cervix, specifically infiltrating the lining of the cervix.
• Stage 2B: The cancer has infiltrated the muscular layer of the cervix.

Stage 3:

• Stage 3A: The cancer has spread beyond the uterus to involve the uterine appendages, such as the fallopian tubes.
• Stage 3B: The cancer has infiltrated the vagina.
• Stage 3C: The cancer has metastasized to nearby pelvic or paraaortic lymph nodes, which are located alongside the abdominal part of the aorta.

Stage 4:

• Stage 4A: The cancer has grown into the bladder or bowel.
• Stage 4B: The cancer has metastasized to distant organs like the lungs, bone, brain, and may also involve the groin or other lymph nodes in the abdominal region (excluding paraaortic lymph nodes).

When cancer spreads to other organs, it is referred to as metastatic cancer.

Understanding the stage of the disease helps healthcare professionals determine the appropriate treatment options and prognosis for individuals with uterine body cancer.

Degree of Differentiation and Treatment of Endometrial Cancer [H2]

The degree of differentiation of uterine body cancers provides valuable information about the aggressiveness of the disease.

Pathologists assess the degree of differentiation by examining the cancer cells under a microscope using biopsy samples. This evaluation compares the structure of the cancer cells to that of the cells they originated from.

Well-differentiated cancer cells closely resemble healthy cells, indicating a slower tumor growth, less malignant behavior, and a milder disease course.

• Well-differentiated tumors are classified as G1.
• Moderately differentiated tumors are classified as G2.
• Poorly differentiated tumors as G3-4.

The less similar the cancer cells are to healthy cells, the more aggressive the disease becomes.

In the treatment of uterine body cancer, most cases are diagnosed at an early stage when the tumor is confined to the uterus and has not spread beyond it. It is crucial for women experiencing bleeding or bloody discharge from the genital tract during menopause to seek immediate medical attention.

In these cases, surgical removal of the uterus, known as a hysterectomy, is typically the primary treatment.

Additional treatments are often unnecessary, but natural alternative therapy protocols, such as DCA, Fenbendazole, 2DG, or 4PBA, can be utilized to sustain remission and prevent future recurrence. Regular follow-up monitoring is also essential.

However, in certain situations where there may be a minimal risk of recurrence or if the surgeon is not fully confident in the completeness of the initial surgery, radiotherapy may be employed after the hysterectomy. This adjuvant radiotherapy aims to further reduce the risk of recurrence and ensure optimal treatment outcomes.

The specific treatment approach for uterine body cancer depends on various factors, including the stage of the disease, the degree of differentiation, and individual patient characteristics. Healthcare professionals work closely with patients to determine the most appropriate treatment plan tailored to their specific needs.

Utilizing Radiotherapy in Managing Endometrial Cancer

Radiotherapy is utilized in the treatment of uterine body cancer when surgery is not feasible for various reasons, such as the disease being at an advanced stage or recurrence. It can be employed to target the tumor and control symptoms.

Chemotherapy and Hormonal Therapy for Endometrial Cancer Treatment

In cases where the cancer has spread to other parts of the body, treatment with the female hormone progesterone may be used to shrink the tumor and manage symptoms. Additionally, chemotherapy may be administered to reduce tumor size and alleviate symptoms in advanced cases of uterine body cancer.

Several key factors influence the choice of treatment, including the stage of the cancer, degree of differentiation, the woman’s age, and her overall health status, including any coexisting medical conditions.

Before proceeding with any treatment, the doctor thoroughly discusses the disease, treatment options, associated risks, and potential side effects with the patient. Treatment cannot commence without the patient’s informed consent.

Prior to consenting to treatment, a woman should inquire about the planned extent of treatment, such as whether it involves surgery or radiotherapy, and understand the advantages and disadvantages of the proposed treatment. It is also important to ask about alternative treatment options, as well as the risks and potential side effects associated with the intended treatment.

Surgery in Uterine Body Cancer Removal

Surgical treatment is the most common approach for early-stage uterine body cancer. It typically involves a total hysterectomy, which entails the removal of the uterus, fallopian tubes, and ovaries. In some cases, the adjacent lymph nodes are also removed during the surgery.

The excised surgical specimens are carefully examined by a pathologist under a microscope to determine if the cancer has spread beyond the uterus.

In most instances, it is confirmed that the disease has not metastasized, and surgery alone is sufficient for treatment. However, if there is even a slight possibility of recurrence, additional radiotherapy may be administered following surgery.

Preparation Before Surgery

To ensure a smooth and successful surgery, it is important to assess the patient’s overall health and the proper functioning of their cardiovascular, respiratory, digestive, and urinary systems.

Typically, the patient will be consulted by a therapist and, if necessary, other medical specialists before the operation. They evaluate the patient’s general health, order necessary tests, and adjust the treatment of any coexisting conditions such as high blood pressure, ischemic heart disease, diabetes, bronchial asthma, and others.

On the day before the surgery, the anesthetist examines the patient, explains the anesthesia that will be administered during the operation, and prescribes a sedative to help the patient rest well.

Emptying the stomach and cleaning the intestines are important prior to surgery. This facilitates the surgeon’s work and ensures that the patient does not experience nausea or bloating after the operation, leading to a faster recovery.

Therefore, on the day before the operation, the patient is provided with only a light breakfast and lunch, and dinner is not allowed. In the evening, only liquids are permitted, and no food or drink is allowed 6-8 hours prior to the operation. A laxative is given the day before the operation, and a cleansing enema is performed in the evening and morning before the procedure.

Ensuring an empty bladder is also essential during the operation, so it is crucial for the patient to urinate before entering the operating room.

Maintaining personal hygiene is highly important. The body’s skin must be clean to minimize the risk of infection. It is necessary to take a shower in the evening before and in the morning of the operation. Special attention should be given to areas of the body where bacteria tend to accumulate, such as the neck, armpits, and groin.

By following these preparations, the patient and medical team can work together to create an optimal surgical environment, reducing the risk of complications and promoting a successful outcome.

Post-Surgery Care

After the surgery, it is encouraged for the patient to begin moving as soon as possible. Even while still in bed, regular leg muscle exercises and deep breathing exercises are important, and these can be taught and assisted by a physiotherapist or a specially trained nurse.

Engaging in moderate physical activity helps prevent post-operative complications such as pneumonia and venous thrombosis, and promotes healing.

In the initial days following the operation, when the patient is unable to eat or drink, intravenous fluid infusions are administered to maintain proper fluid balance.

The abdominal wound is dressed every day or every other day. To prevent the accumulation of secretions in the abdominal cavity, several drainage tubes are left in place by the surgeon during the operation. These tubes allow fluids from the abdomen and the wound to drain outside into a plastic bag.

Monitoring the amount and color of the fluid collected in the bag helps the doctor assess the progress of healing. Once the secretion stops accumulating, the tubes are removed.

To prevent thromboembolic complications, especially if the patient has dilated calf veins, special elastic stockings or elastic bandages are worn on the legs during and for several days after the operation. These aids improve blood circulation and reduce the risk of blood clots forming in the veins.

Throughout the post-operative period, a ward nurse provides assistance and support with all necessary procedures. They play a crucial role in the patient’s recovery and well-being.

By adhering to post-surgery care guidelines, the patient can optimize their recovery process, minimize complications, and regain their health as efficiently as possible.

After the operation, some patients may experience difficulty in urinating. To monitor urine output and assess any abnormalities, a thin and flexible tube called a catheter is inserted through the urethra into the bladder.

The catheter is connected to a urine collector, allowing urine to flow freely. Typically, the catheter is removed after two or three days if there are no complications.

Pain in the abdominal wound and abdomen is common after the operation. Pain relief medication is administered to alleviate discomfort. If the pain persists despite medication, it is important to inform the doctor or nurse so that appropriate adjustments can be made to the pain management plan. With effective pain treatment, the patient should not experience significant pain.

In most cases, around 8-10 days after the operation, once the abdominal wound has healed and sutures have been removed, the patient can be discharged and return home. The doctor will provide a medical history note to the patient’s family doctor, outlining the diagnosis, treatment received, and any recommended follow-up care.

Upon discharge, the doctor advises the patient to avoid intense physical activity, heavy lifting, and driving for the first three months after surgery.

Concerns about the impact of surgery on a woman’s sex life may arise. It is generally advisable to wait approximately six weeks after surgery and ensure that the surgical area has fully healed before resuming sexual activity.

While most women do not experience issues with their sex life after surgery, some may notice a shortening of the vagina, which can cause discomfort during intimate relations. It is important to note that there is no risk of transmitting malignancy to a partner.

For women who undergo surgery while still menstruating, the removal of the ovaries and uterus leads to premature menopause, as the production of the hormone estrogen is halted. This can result in symptoms such as hot flashes, sweating, vaginal dryness, decreased sexual desire, and discomfort during intercourse. Women should consult with a gynecologist to receive guidance on managing these symptoms and improving their overall comfort and well-being.

After undergoing a hysterectomy, a woman is no longer able to conceive and have children. It is an irreversible outcome of the procedure.

Radiotherapy Treatment for Endometrial Cancer

Radiotherapy is another treatment option for uterine body cancer. It involves the use of high-energy ionising radiation to destroy cancer cells. Similar to surgery, radiotherapy is a localized treatment method that targets the affected organs and surrounding tissues.

Radiotherapy for uterine body cancer is employed in several situations:

• When there is a risk of cancer recurrence after surgery.
• When a patient chooses not to undergo surgery or if surgery is not feasible due to other medical conditions.
• When the cancer has spread extensively beyond the uterus.
• When the disease has relapsed.

Both external and internal radiotherapy techniques can be utilized for treating uterine body cancer, and often a combination of both methods is employed.

External radiotherapy involves directing a beam of ionising radiation from a radiation machine at a distance from the body’s surface, targeting the specific area to be irradiated. This method allows for the irradiation of larger tissue volumes such as the uterus and pelvic lymph nodes. External radiotherapy sessions are typically administered daily over a specified period.

It is important to consult with healthcare professionals to determine the most suitable treatment approach based on the individual’s specific condition and circumstances.

Radiotherapy, also known as irradiation, is conducted by a radiation oncologist in a dedicated radiotherapy department, either as an inpatient or outpatient procedure. Modern external irradiators utilize linear accelerators to deliver ionising radiation.

While radiotherapy aims to destroy cancer cells, it also affects healthy tissues within the irradiation area. To maximize the benefits of radiotherapy and deliver the necessary radiation dose to the tumor while preserving surrounding healthy tissues and organs, precise planning and calculations are crucial.

The radiation treatment plan involves a collaborative effort among the radiation oncologist, radiologists, medical physicists, and clinical radiobiologists, forming a comprehensive radiation treatment planning team.

The goal of radiotherapy planning is to ensure that the tumor receives the appropriate dose of radiation from all directions, effectively targeting and destroying cancer cells. Simultaneously, measures are taken to minimize radiation exposure to adjacent healthy tissues and organs, reducing the potential for damage. This meticulous planning process aims to achieve the best possible outcome while minimizing side effects and preserving the overall well-being of the patient.

During the planning phase of radiotherapy, CT scans of the pelvic area are taken to obtain cross-sectional X-ray images. The radiation oncologist and radiotherapist carefully mark the specific tissues to be irradiated, including the uterus, nearby tissues, and lymph nodes.

Medical physicists then determine the optimal number and size of irradiation fields, calculate the angles at which the radiation beams should be directed, and determine the appropriate dose and duration of radiation.

The goal is to ensure that the intended tissues receive an even and accurate dose of radiation while minimizing the impact on healthy nearby organs.

The detailed radiation treatment plan, including all the parameters, is documented and followed by the radiation oncologist and the assisting radiological technologist for each radiation session.

Precise positioning is crucial to ensure that the radiation beam is delivered consistently and accurately. To achieve this, the patient’s pelvic skin is tattooed with special marks in strategic locations.

These marks help the radiotherapist position the patient correctly and ensure precise beam targeting. Although these marks are permanent, they are usually small and barely noticeable. In some cases, the boundaries of the radiation fields may also be marked on the abdominal skin using a special pencil. These marks can be washed off after the completion of radiotherapy.

Preparation for radiotherapy may take several days or up to a week. Once all preparations are complete, the actual radiotherapy sessions can commence. The patient is positioned comfortably on the radiation table, typically lying on her back.

During each session, the patient is left alone in the radiation room while the treatment is administered. The ionising radiation is carefully delivered according to the treatment plan, targeting the specific areas requiring treatment.

It is important to ensure consistency in the delivery of radiation, so that the beam accurately hits its intended target with each session. This attention to precision helps maximize the effectiveness of the treatment and minimize the risk of missing the intended areas.

When undergoing external beam radiotherapy, patients typically do not feel anything during the treatment. They are required to lie still for a few minutes while the radiation is delivered. As mentioned earlier, the tumor is irradiated from various angles, and the position of the radiation machine’s head may change throughout the session.

The doctor will inform the patient in advance to prevent any unnecessary anxiety. The doctor can monitor the treatment process from an adjacent room through a TV screen and can even communicate with the patient.

Radiotherapy treatments can be carried out in both inpatient and outpatient settings. The typical daily dose of radiation to the irradiated area is around 1.8-2 Gy (grays), and the total dose for the entire course of treatment is determined by the radiologist.

The specific dose depends on factors such as whether the radiotherapy is being performed after surgery, whether it is combined with internal radiotherapy, or if it is aimed at treating recurrent disease.

External beam radiotherapy can cause skin irritation in the irradiated area of the abdomen. The skin may become more sensitive, itchy, red, and irritated due to radiation-induced inflammation.

It is important to avoid cleaning the skin with alcohol, using hot water, or applying deodorants, scented soaps, or creams.

If signs of skin damage appear, it is recommended to consult a doctor who can prescribe special ointments or other therapeutic measures.

In cases of internal radiotherapy, also known as brachytherapy, the radiation source is placed very close to or inside the tumor or the body cavities near the tumor. This allows for a concentrated dose of radiation to be delivered to the tumor while minimizing exposure to surrounding tissues.

Brachytherapy Treatment for Endometrial Cancer

Brachytherapy is used after uterine surgery to target the upper part of the vagina, where malignant cells from the uterine body tumor may have infiltrated. It can be used as an alternative to surgery or in combination with external radiotherapy, depending on the individual case.

Modern brachytherapy techniques have simplified the process and made treatment sessions shorter and less fatiguing for patients. Small amounts of ionising radiation are carefully delivered directly to the tumor site, resulting in effective treatment with minimal impact on surrounding tissues.

During brachytherapy, the radiation sources are automatically transported from the machine’s source receptacle to the vaginal area through thin plastic tubes.

The sources change their position during the session to ensure even irradiation of the vaginal walls. The duration of irradiation, source positions, and doses are pre-calculated by medical physicists, and the brachytherapy machine handles these processes automatically.

The patient undergoes the session alone in the irradiation room, while the doctor monitors them on a video screen. A brachytherapy session typically lasts a few to several minutes, and the full planned radiation dose is usually achieved over 4-5 sessions.

In cases where brachytherapy is performed on non-operated patients, the goal is to internally irradiate the uterine body and the upper part of the vagina with the required dose.

The sources of ionising radiation are guided automatically from the apparatus’ source store to the uterine cavity and the area of the vagina to be irradiated.

During radiotherapy, whether external or internal, there can be early side effects. Irritation of the rectal lining may cause increased urge to defecate or even diarrhea. Soreness around the anus may also occur.

It is important to inform the radiotherapist about these symptoms, as they can prescribe appropriate medications and provide dietary advice.

Radiation can also cause inflammation of the bladder, known as cystitis, leading to increased frequency of urination and a burning sensation during urination. Discussing these symptoms with the doctor is important so that appropriate medication can be prescribed.

Weakness and fatigue may occur as side effects of radiotherapy, the severity of which depends on the dose and duration of treatment. Patients are usually informed about these potential side effects before starting treatment, and it is important to get sufficient rest during the treatment period, especially if daily visits are required.

Most of these unpleasant sensations and side effects subside within a few weeks after treatment. However, some symptoms may persist or recur. In such cases, it is advisable to inform your general practitioner (GP) who can provide advice or refer you to a radiation oncologist for further guidance.

It is important to note that during radiotherapy, the patient does not emit radiation and can interact with other people in the same way as before.

Late side effects of radiotherapy for endometrial cancer, although less frequent with improved equipment and techniques, can still occur. Chronic irritation of the rectum and bladder may lead to persistent symptoms such as diarrhea and increased urination. Fragility of blood vessels lining the bladder and rectum can result in occasional bleeding in the urine or feces, which may last for months or even years. If blood is noticed in the urine or feces, it is important to consult a doctor for proper evaluation and treatment.

In some cases, if the lymph nodes in the pelvis are also irradiated, there is a rare possibility of developing lymphedema, a permanent swelling of the lower limbs.

Hormone Therapy for Endometrial Cancer

Hormone therapy using progesterone can be employed to treat advanced uterine cancer by reducing the size of the tumor and alleviating related symptoms. Progesterone, either in the form of synthetic tablets or injections, is administered as treatment.

Side effects of progesterone treatment are generally mild, with some women experiencing mild nausea, increased appetite, weight gain, or mild muscle cramps.

Chemotherapy for Endometrial Cancer

Chemotherapy may be used when the disease recurs or has spread to distant organs and is unresponsive to progesterone treatment. Chemotherapy involves the administration of drugs through intravenous injections to reduce the size of the tumor and relieve symptoms.

Side effects of chemotherapy for uterine cancer can include a decrease in blood cell counts (leukocytes, erythrocytes, and hemoglobin), weakness, nausea, vomiting, hair loss, mouth sores, and reduced immune function. These side effects are typically temporary and gradually subside after the completion of treatment.

It is important to discuss potential side effects and management strategies with the healthcare team to minimize their impact and ensure appropriate supportive care throughout the treatment process.

Guidelines for Post-Treatment Monitoring in Endometrial Cancer Patients

Monitoring the patient after treatment for uterine body cancer is crucial to detect any potential recurrence or complications and ensure ongoing care.

The follow-up is typically conducted by the general practitioner in collaboration with gynecologists and oncologists.

The frequency and specific tests performed during follow-up may vary depending on individual circumstances, but generally, the following guidelines are recommended:

• In the first two years after treatment, check-ups are advised every 3-6 months. For the third, fourth, and fifth years, follow-up visits are recommended 1-2 times a year.

• During each check-up, a gynecological examination is conducted, including an oncocytological vaginal smear (Pap test).

• Ultrasound examinations of the liver, kidneys, abdominal paraaortic and pelvic lymph nodes are typically performed about twice a year to monitor for any spread of the disease.

• A chest X-ray is usually conducted once a year.

• Additional tests such as CT scans of the pelvis or other body regions, radioisotope renal function tests, or other diagnostic procedures may be ordered if deemed necessary based on individual circumstances and symptoms.

• After five years of treatment, follow-up tests are usually recommended once a year.

It is important for patients to promptly report any symptoms that may raise suspicion of a relapse between scheduled check-ups to their healthcare provider.

The Role of Clinical Trials in Advancing Cancer Treatments

Clinical trials play a significant role in advancing cancer treatment options. These trials are conducted to compare the effectiveness of new treatments, such as novel anti-cancer drugs, hormone therapy, or biological therapy, against established standard treatments.

Randomized controlled trials, where treatment allocation is determined by a computer rather than the treating physician or patient, help ensure unbiased results. Participating in clinical trials allows patients to access potentially more effective treatments, contribute to scientific research, and potentially improve their own outcomes and quality of life.

Patients should discuss with their healthcare providers the availability of clinical trials and whether they are suitable candidates for participation based on their specific circumstances.

You are correct. In a clinical trial, a treatment is considered more effective if it demonstrates superior anti-tumor efficacy or if its efficacy is comparable to the standard treatment while causing fewer side effects.

The decision to participate in a clinical trial is voluntary, and patients have the right to withdraw their consent at any time if they change their mind. If a patient chooses not to participate, they will receive the standard treatment.

Before enrolling a patient in a clinical trial, the doctor explains the purpose of the study, the treatment being investigated, and why the patient has been invited to participate. It is important for patients to have a clear understanding of the study and its potential benefits and risks before giving their consent. Patients who decide to participate in a clinical trial may have the opportunity to receive a treatment that has undergone preliminary testing and may be more effective than the standard treatment.

Participating in clinical trials contributes to the advancement of oncology science, benefiting not only the individual patient but also future patients.

Research studies often require the collection of blood, bone marrow, or tissue samples from patients. Researchers seek patients’ consent to use these samples for research purposes, and the samples may be stored and used in future studies when appropriate conditions arise.

It is important to note that the results of scientific research may take time to be published and become widely known, but they have the potential to greatly benefit other patients in the future.

Patients should discuss with their healthcare providers the options for participating in clinical trials and the potential impact of their participation on advancing medical knowledge and improving cancer treatments.

The fear and uncertainty that patients experience upon receiving a cancer diagnosis are understandable. Thoughts of mortality and concerns about pain and suffering may arise. It is important to remember that advancements in the treatment of uterine body cancer have led to improved outcomes, particularly when the disease is detected early. Even in cases where the disease is more advanced, treatment options are available to manage the disease, alleviate symptoms, and enhance the patient’s quality of life and overall prognosis.

It is common for patients to have questions and concerns about their future, treatment options, and potential outcomes. Open and honest communication with healthcare providers is crucial to address these fears and uncertainties. Healthcare professionals can provide information about the disease, treatment options, and potential side effects, helping patients gain a better understanding of their situation and providing reassurance.

Support from family, friends, and mental health professionals can also be valuable during this time.

It is essential for loved ones to empathize with the patient’s emotions and offer support. Patients may find comfort in discussing their feelings, concerns, and fears with others who are going through similar experiences.

It is important to note that everyone copes with their illness differently, and there is no right or wrong way to feel. The range of emotions experienced by patients is a normal part of the process of coming to terms with the diagnosis and adjusting to life with cancer.

Seeking support from healthcare professionals and engaging in self-care practices can help patients navigate these emotions and maintain their overall well-being.

It is natural for patients to have concerns about pain and potential side effects of treatment. However, it is important to note that modern pain management techniques and medications can effectively control and alleviate pain, ensuring that patients are comfortable and pain-free throughout their treatment journey. Healthcare professionals are skilled in assessing and managing pain, and they will work closely with patients to develop personalized pain management plans that address their specific needs.

Patients may also have worries and questions about their prescribed treatment, including how it works and potential side effects. It is highly recommended to have open and detailed discussions with the treating doctor to address these concerns. Making a list of questions or concerns beforehand can help ensure that all important aspects are covered. It is completely acceptable to ask the doctor to repeat or clarify information that is not fully understood. Open communication with the healthcare team is crucial in order to have a clear understanding of the treatment process and what to expect.

Some patients may experience anxiety or fear related to the hospital environment, especially if it is their first experience of hospitalization. In such cases, it is important to communicate these concerns with the doctor or nurse. They can provide reassurance, explain the hospital procedures, and address any specific fears or worries the patient may have. The healthcare team is there to support and guide patients throughout their treatment journey, and they understand the importance of addressing emotional well-being alongside medical care.

Living with uncertainty about the future can indeed be challenging and cause stress. It is important to remember that each patient’s journey and response to treatment is unique, making it difficult to provide definitive answers or predictions about individual outcomes. Sharing experiences and connecting with others who have faced similar challenges can provide valuable support and reassurance. Support groups, online communities, or counseling services may be available to help patients connect with others who understand their experiences and offer emotional support.

Navigating Emotional Challenges and Seeking Support During the Cancer Journey

Overall, open communication, seeking support from healthcare professionals, and connecting with fellow patients can help alleviate fears and provide a sense of reassurance during the cancer journey.

Denial, anger, blame, and guilt are common emotional responses that some individuals may experience when faced with a cancer diagnosis. It is important to understand that these feelings are normal and a part of the coping process. Each person may react differently, and there is no right or wrong way to feel.

Some individuals may prefer not to discuss their illness or only talk about it as much as necessary. If a patient feels this way, it is important for them to communicate their preferences to their loved ones, letting them know that they may need some time and space before discussing the illness further.

On the other hand, it is possible for family members or friends to be in denial about the diagnosis or downplay the severity of the illness. In such cases, it can be helpful for the patient to express their feelings and explain their need for support and understanding. Open communication is key, allowing the patient to share their emotions and concerns with their loved ones.

Feelings of anger are also common, as individuals may question why they have been affected by cancer and why it happened to them. It is important for patients to understand that these feelings are not uncommon and should not be suppressed or ignored.

Expressing anger in a healthy and constructive manner, such as through open communication or seeking support from professionals, can be helpful in processing these emotions.

Blame and guilt are often associated with attempting to find a cause or explanation for the illness. However, it is important to remember that the exact causes of cancer are often complex and multifactorial, and blaming oneself or others is generally not productive.

It is important to focus on moving forward and accessing appropriate medical care and support.

If dealing with these emotional challenges becomes overwhelming, seeking the assistance of a psychologist or mental health professional can be beneficial. They can provide support, guidance, and tools to help individuals navigate their emotions and cope with the impact of cancer.

It is essential for patients to remember that they are not alone in their journey and that support from healthcare professionals, loved ones, and support groups is available to them.

Resentment, the desire for solitude, depression, and the challenges of discussing the illness within the family are additional feelings that individuals may experience when faced with cancer. It is important to acknowledge and address these emotions in order to provide support and promote healthy coping strategies.

Feelings of resentment may arise when individuals compare themselves to others who do not have cancer. It is a natural response to question why it happened to them and not someone else. Expressing these feelings and discussing them openly can help alleviate anger and guilt.

There may be moments when individuals want to be alone with their thoughts and emotions. It is important for loved ones to understand and respect this need for solitude while also maintaining open lines of communication.

Assuring them that there will be opportunities to discuss the illness when the individual is ready can help alleviate any feelings of being shut out.

Depression can sometimes accompany a cancer diagnosis and should be addressed with the help of a healthcare professional. They can provide appropriate support, including the possibility of prescribing antidepressant medications or referring the individual for specialized advice.

Communication within the family about the diagnosis can be challenging, particularly if there are decisions to withhold or alter information. It is important to recognize that secrets and distorted information can lead to isolation and tension within the family. Open and honest communication is generally more beneficial in fostering understanding and support among family members.

When providing support, seeking out optimistic friends or relatives can be helpful. Optimistic attitudes can provide encouragement and a positive perspective during the challenging journey of cancer treatment and recovery.

It is essential to remember that each person’s experience with cancer is unique, and their emotional responses may vary. Seeking professional guidance and support, such as counseling or support groups, can provide additional assistance in navigating these complex emotions and promoting overall well-being.

Understanding one’s illness and its treatment can empower individuals to actively participate in their own care. It is important to obtain information from reliable sources to avoid unnecessary fear and misinformation.

Sharing experiences with other women who have had a similar diagnosis can also provide valuable insights, but it is important to remember that each case is unique, and what works for one person may not work for another.

Seeking Support During the Cancer Experience

Taking care of oneself physically and emotionally is crucial during the cancer journey. This includes maintaining a healthy lifestyle, following the treatment plan, and seeking support from healthcare professionals, family, and friends. Engaging in activities that bring joy and relaxation can also help alleviate stress and promote overall well-being.

Finding support networks and resources can be beneficial in navigating the challenges of a cancer diagnosis.

Support groups, counseling services, and online communities can provide a sense of connection, understanding, and guidance. It is important to remember that seeking support is not a sign of weakness, but rather a proactive step towards self-care and coping.

Lastly, being patient and kind to oneself is essential. It is natural to experience a range of emotions and to have ups and downs throughout the journey. Showing self-compassion and allowing oneself to grieve, heal, and find hope can contribute to a healthier and more positive outlook.

Remember, every person’s experience with cancer is unique, and finding what works best for oneself is key. It is important to communicate openly with healthcare professionals, rely on trusted sources of information, and reach out for support when needed.

It’s important for patients to understand that they may need to adapt their activities and routines based on their energy levels and physical abilities. Engaging in simple self-determined tasks can help restore confidence and provide a sense of accomplishment.

This could involve maintaining a healthy and balanced diet, learning relaxation exercises, or gradually incorporating regular exercise based on individual capabilities and goals.

However, it’s important to note that everyone’s preferences and coping mechanisms may differ. Some individuals may find comfort in maintaining their daily routines, while others may choose to take a break or focus on hobbies.

It’s essential to listen to one’s own needs and do what brings them joy and peace during this challenging time.

Seeking support from others can also be beneficial. Talking to someone who is not directly involved in the illness, such as a specialist at a Cancer Information Centre or a religious leader, can provide a fresh perspective and emotional support.

Additionally, community resources like volunteer help or home care services may be available to assist with practical tasks and provide additional support.

If feelings of depression, anxiety, or helplessness become overwhelming, it may be necessary to seek professional help. Mental health professionals, such as therapists or counselors, can provide specialized support and guidance during difficult times.

It’s important to remember that seeking help is a sign of strength and can contribute to overall well-being.

Ultimately, finding the right balance of self-care, support from others, and professional assistance is important for navigating the challenges of living with cancer.

Each individual’s journey is unique, and it’s essential to prioritize one’s own well-being and seek the necessary support when needed.

Social assistance is an important aspect of supporting cancer patients during their treatment. If a person is unable to work due to their illness, they can receive a sickness certificate, which provides financial support during the period they are unable to work.

Based on this assessment, benefits are calculated and paid to the patient. It is recommended to consult with a social worker in institutions providing oncological assistance for more detailed information on social benefits and support available.

In conclusion, it is important to continue seeking knowledge and understanding about uterine cancer. With modern treatments, even advanced disease can be managed effectively, and early detection greatly increases the chances of cure.

Wishing you good health and strength on your journey.